- Home
- ALDX vs NBH Comparison
ALDX vs NBH Comparison
Compare ALDX & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- NBH
- Stock Information
- Founded
- ALDX 2004
- NBH 2002
- Country
- ALDX United States
- NBH United States
- Employees
- ALDX N/A
- NBH N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- ALDX Health Care
- NBH Finance
- Exchange
- ALDX Nasdaq
- NBH Nasdaq
- Market Cap
- ALDX 304.9M
- NBH 317.5M
- IPO Year
- ALDX 2014
- NBH N/A
- Fundamental
- Price
- ALDX $6.58
- NBH $10.37
- Analyst Decision
- ALDX Strong Buy
- NBH
- Analyst Count
- ALDX 2
- NBH 0
- Target Price
- ALDX $10.00
- NBH N/A
- AVG Volume (30 Days)
- ALDX 666.8K
- NBH 85.9K
- Earning Date
- ALDX 05-01-2025
- NBH 01-01-0001
- Dividend Yield
- ALDX N/A
- NBH 4.34%
- EPS Growth
- ALDX N/A
- NBH N/A
- EPS
- ALDX N/A
- NBH 0.12
- Revenue
- ALDX N/A
- NBH N/A
- Revenue This Year
- ALDX N/A
- NBH N/A
- Revenue Next Year
- ALDX N/A
- NBH N/A
- P/E Ratio
- ALDX N/A
- NBH $87.04
- Revenue Growth
- ALDX N/A
- NBH N/A
- 52 Week Low
- ALDX $2.75
- NBH $8.75
- 52 Week High
- ALDX $7.20
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- ALDX 54.16
- NBH 34.11
- Support Level
- ALDX $6.16
- NBH $10.30
- Resistance Level
- ALDX $7.20
- NBH $10.50
- Average True Range (ATR)
- ALDX 0.62
- NBH 0.10
- MACD
- ALDX -0.02
- NBH -0.03
- Stochastic Oscillator
- ALDX 74.38
- NBH 13.33
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.